Dynavax Technologies (DVAX) Short Interest Ratio & Short Volume

Short interest is the volume of Dynavax Technologies shares that have been sold short but have not yet been covered or closed out. As of November 15th, investors have sold 21,000,000 shares of DVAX short. Learn More on Dynavax Technologies' current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. DVAX shares currently have a short interest ratio of 9.0. Learn More on Dynavax Technologies's short interest ratio.

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Dynavax Technologies: Walleye Capital LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Dynavax Technologies saw a increase in short interest in November. As of November 15th, there was short interest totaling 21,000,000 shares, an increase of 11.5% from the previous total of 18,840,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Here is how the short interest of companies in the industry of "biotechnology" compare to Dynavax Technologies: Halozyme Therapeutics, Inc. (8.30%), Ionis Pharmaceuticals, Inc. (7.59%), Alkermes plc (10.43%), Amicus Therapeutics, Inc. (7.03%), Geron Co. (11.60%), Ligand Pharmaceuticals Incorporated (4.40%), MannKind Co. (15.73%), Celldex Therapeutics, Inc. (11.80%), BioCryst Pharmaceuticals, Inc. (8.93%), Myriad Genetics, Inc. (4.05%),

As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($4.85 billion), Charter Communications, Inc. ($4.81 billion), International Paper ($2.96 billion), Cencora, Inc. ($2.40 billion), Paychex, Inc. ($2.38 billion), Lululemon Athletica Inc. ($2.05 billion), SoFi Technologies, Inc. ($2.03 billion), Live Nation Entertainment, Inc. ($1.93 billion), Onsemi ($1.82 billion), and Tractor Supply ($1.65 billion). View all of the most shorted stocks.

Short selling DVAX is an investing strategy that aims to generate trading profit from Dynavax Technologies as its price is falling. DVAX shares are trading up $0.07 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Dynavax Technologies occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of DVAX, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including DVAX, twice per month. The most recent reporting period available is November, 15 2024.